Study

Design

Population

Outcomes

Results

Adjustments

Comments

Macfarlane et al., 2005 (Update)

Mortality cohort; 13-year follow-up

51,753 UK GW deployed veterans and 50,808 era veterans, randomly selected, matched by age, sex, service branch, rank; also fitness for active service in the army and Royal Air Force

Mortality due to malignant neoplasms

GWVs (123 deaths) compared to era veterans (130 deaths):

MRR 1.01 (95% CI 0.79-1.30)

 

Complete and long-term follow-up; cohort of moderate size; potentially other uncontrolled confounders such as smoking

NOTE: BIRLS = Beneficiary Identification Records Locator System; CCD = Canadian Cancer Database; CMD = Canadian Mortality Database; DMDC = Defense Manpower Data Center; GW = Gulf War; GWV = Gulf War veteran; HR = adjusted hazard ratio; MMR = mortality rate ratio; NDI = National Death Index; NDV = nondeployed veteran; NHSCR = National Health Service Central Register; PHQ = Patient Health Questionnaire; PIR = proportional incidence ratio; RR = adjusted risk ratio; SEER = Surveillance Epidemiology and End Results; SF-12 = 12-item short form health survey; SIR = standardized incidence ratio; SMR = standardized mortality ratio; SRR = standardized rate ratio.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement